Pathological analysis confirmed the diagnosis of invasive breast carcinoma, which was negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and invasive breast carcinoma.